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Cogan syndrome is a systemic disease manifesting interstitial keratitis, sensorineural hearing loss, tinnitus, and
rotatory vertigo. Renal complications of this syndrome are very rare. We encountered an adolescent with Cogan
syndrome complicated by aortitis and anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
At the age of 14, the patient showed proteinuria in a screening urinalysis at school and was found to lack a right
radial pulse. Magnetic resonance angiography disclosed right subclavian artery stenosis. Examination of a renal
biopsy specimen showed ANCA-positive crescentic glomerulonephritis. Steroid and immunosuppressant treatment
improved renal function and histopathology, but repeated recurrences followed. At 18, the patient developed
rotatory vertigo, a sense of ear fullness, and sensorineural hearing loss. The patient was diagnosed with Cogan
syndrome. We know of no previous description of ANCA-positive crescentic glomerulonephritis in children with
Cogan syndrome. Accordingly, evaluation of aortitis in childhood should include not only otolaryngologic and
ophthalmologic examinations, but also periodic urine examination and renal function tests.
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VertigoBackground
Cogan syndrome, a rare systemic disease characterized by
interstitial keratitis, sensorineural hearing loss, tinnitus,
and rotatory vertigo, often manifests constitutional symp-
toms such as fever and headache [1]. Typical Cogan syn-
drome includes interstitial keratitis, though atypically
other ocular lesions such as cataracts may be seen [2].
While autoimmunity has been suggested as a cause, spe-
cific mechanisms remain unclear [2,3]. Complications in-
clude systemic necrotizing vasculitis in half of patients,
10% of whom develop aortitis. Cardiovascular disorders
closely underlie mortality in this disease [4].
Only rarely is Cogan syndrome complicated by nephrop-
athy, which sometimes causes progressive renal dys-
function [3,5]. Histopathologic findings may include
glomerulonephritis, renal vasculitis, cortical scars, and
renal infarction. In addition, tubulointerstitial nephritis
has been reported [6].* Correspondence: tsukasa@med.kindai.ac.jp
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plicated by aortitis and anti-neutrophil cytoplasmic anti-
body (ANCA)-associated glomerulonephritis.Case presentation
The patient now is 25-year-old. When he was 14, protein-
uria was detected in a urinary screening examination at
school. Referred to a local hospital for evaluation of pro-
teinuria, he lacked a right radial pulse, raising suspicion of
aortitis. This was confirmed when magnetic resonance
angiography (MRA) demonstrated stenosis of the right
subclavian artery (Figure 1a). No stenotic changes suspect-
ing aortitis were observed in any other arteries including
renal artery and bilateral iliac arteries. No abnormal chest
radiologic findings including hilar or mediastinal nodal
enlargement suspecting sarcoidosis were demonstrated by
chest X-ray examination coupled with computed tomog-
raphy. He was treated with oral prednisolone (PSL) and
aspirin. At age 16, he was referred to our hospital, when
proteinuria had come to exceed 4 g/day. The patient hadral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The evaluation of the patient's aortitis and renal disorder. MRA (a) and renal histologic (b-d, Periodic acid-Schiff stain) findings in
the patient. MRA showed stenosis of the right brachiocephalic artery and proximal obstruction in the right subclavian artery (indicated by arrows).
Renal histologic findings while proteinuria was worsening included mesangial proliferation with circumferential crescent formation (b, x200) and
periglomerular mononuclear cell infiltration (c, x100). Small renal arteries showed medial thickening, endothelial cell proliferation, and thrombosis
(d, x100, indicated by arrows). After treatment with PSL and an immunosuppressant, glomerular and tubular interstitial lesions decreased (e, x100).
However, repeated relapses occurred, and a recent specimen showed sclerotic glomeruli (f, x200).
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his family history was unremarkable.
On admission, urine examination showed 50–99 red
blood cells per high-power field and heavy proteinuria
(3.1 g/dL). The urinary β2-microglobulin concentration
was normal (218 μg/dL, normal, below 250), and neither
leukocyturia nor bacteriuria was present. Hematologic
examination results included a white blood cell count of
7000/μL, a red blood cell count of 468 × 104/μL, a platelet
count of 296 × 103/μL, and an erythrocyte sedimentation
rate (ESR) of 85 mm/h. The C-reactive protein concentra-
tion was 0.3 mg/dL, arguing against severe bacterial infec-
tion. Blood biochemical results included a total protein
concentration of 6.6 g/dL; albumin, 3.5 g/dL; blood ureanitrogen (BUN), 28 mg/dL; creatinine, 0.85 mg/dL; cystatin
C, 1.10 (normal range, 0.56 to 0.87 μg/L). Creatinine clear-
ance (Ccr) was 70.3 mL/min/1.73 m2, indicating mild renal
dysfunction. Concentrations of electrolytes, immunoglobu-
lin (Ig) G and serum complement concentrations were
normal. The serum myeloperoxidase-ANCA concentration
was increased (21 ELISA units or EU; normal, ≤ 10), but
proteinase-3 (PR-3) was not detected. Antinuclear antibody
(ANA), anti-DNA antibody, rheumatoid arthritis hemag-
glutinatin antibody (RAHA), and anti-cyclic citrullinated
peptide (CCP), as well as anti-SS-A/Ro, anti-SS-B/La,
and anti-RNA antibodies all were negative. Serum con-
centration of sialylated carbohydrate antigen KL-6 was
normal (125 U/mL, normal range, >500). Treponema
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creased serum angiotensin-converting enzyme nor chest
radiologic findings suggesting sarcoidosis were present.
A renal biopsy specimen included 34 glomeruli, 10 of
which showed crescents. Some circumferential crescent for-
mation was seen (Figure 1b). Two glomeruli showed hyali-
nization. Marked mononuclear cell infiltration was present
in the interstitium, mainly near glomeruli (Figure 1c). Im-
munofluorescence examination showed no deposition of
IgG, IgA, or complement components. Based on these find-
ings, a diagnosis of ANCA-positive, pauci-immune cres-
centic nephritis was made.
Therapy was initiated with PSL (including methylpred-
nisolone pulse therapy), cyclophosphamide (2 mg/kg/day),
warfarin (1 mg/day), and an angiotensin-converting
enzyme (ACE) inhibitor. After about 6 months, urinary
protein excretion decreased to 0.3 g/day, representing a
favorable response. To further evaluate effectiveness of
treatment, follow-up renal biopsy was performed. The
specimen showed decreases of mesangial proliferation,
crescents, and periglomerular mononuclear cell infiltra-
tion (Figure 1d). Accordingly, the PSL dose was tapered,
but proteinuria recurred. PSL was increased, and cyclo-
sporine A (CyA) was added. Considering nephrotoxicity
of CyA, serum concentration of CyA was strictly kept
below 100 ng/mL, but the patient’s course has continued
to show repeated remissions and exacerbations. Most re-
cently, serum creatinine was 2.2 mg/dL, and cystatin C,
2.1. Ccr was 47.6 mL/min/1.73 m2, indicating moderate
renal dysfunction.
At age 18, the patient complained of rotatory vertigo,
a sense of ear fullness and difficulty hearing. Audiologic
testing showed thresholds of 24.3 db for the right ear
and 39.5 db for the left, indicated bilateral sensorineural
hearing loss. As Cogan syndrome now was suspected,
ophthalmologic examination was performed. Cataracts
were present, being more severe in the left eye. Keratitis
and uveitis were absent. Based on these findings, a diag-
nosis of atypical Cogan syndrome was made.
Discussion
Cogan syndrome rarely is complicated by renal disease
[3,5]. In such instances, histopathologic diagnosis have
been glomerulonephritis and renal sclerosis caused by IgA
nephropathy and membranoproliferative glomeruloneph-
ritis (MPGN) [2,7]. Development of Cogan syndrome dur-
ing childhood also is rare. As for ANCA-positive vasculitis,
only 1 Cogan syndrome patient with renal vasculitis has
been reported [8]. Concerning ANCA-associated glomer-
ulonephritis as a complication, a single elderly Japanese
patient has been reported [9], but we know of no previous
childhood-onset patients with this complication. In our
patient, proteinuria was the first finding that ultimately led
to the diagnosis of Cogan syndrome, but asymptomaticonset of aortitis may have preceded onset of nephropathy.
As vestibular dysfunction and sensorineural hearing loss
developed only in late adolescence, definite diagnosis of
Cogan syndrome was delayed. However, vestibular dys-
function and sensorineural hearing loss do not always de-
velop simultaneously with other components of Cogan
syndrome [10]. Once Cogan syndrome was suspected, we
performed an ophthalmologic examination, finding cata-
racts but no definite findings of interstitial keratitis. We
therefore diagnosed the patient with atypical Cogan syn-
drome. He did not complain of symptoms suspecting
keratitis or uveitis, but since he was continuously treated
with PSL and an immunosuppressant, and already he had
cataracts when examined, disease activity of keratitis may
have been inhibited at that time. In Japan, about 5000 pa-
tients are believed to have aortitis, with only 1% to 2% be-
ing children [11]. Therefore, in children with aortitis,
follow-up to detect possible development of additional
Cogan syndrome components is necessary.
The pathogenetic mechanism underlying Cogan syndrome
remains unclear. However, infection with Chlamydia pneu-
moniae or reoviruses has preceded onset of the syndrome
in about 50% of patients [1,3,12,13]. In addition, de-
tection of autoantibodies has been reported in a Cogan
syndrome patient [13]. Accordingly, abnormal autoimmun-
ity triggered by respiratory infection might be responsible
for development of Cogan syndrome. Candidate anti-
gens showing reactivity with a patient’s antibodies in-
clude DEP-1/CD148 Cogan peptide and connexin 26
[13]. DEP-1/CD148 Cogan peptide is expressed on the
epithelia of the inner ear, endothelial cells, lymphocytes,
and the kidney, while connexin 26 is present in the
inner ear. These molecules could be associated with
vestibular dysfunction and sensorineural hearing loss.
We intend to evaluate this possibility in our patient. In
addition to these antigens, reovirus III major core pro-
tein lambda 1 has been suggested [13], but this pro-
tein’s association with development of the syndrome
remains unclear. On the other hand, little is known
about pathogenesis of ANCA-associated glomerulo-
nephritis. In addition to differences among races and
genetic factors such as HLA-DR9, involvement of infec-
tion and environmental factors has been suggested [14].
Precise mechanisms of the concurrence of these two
diseases remains still unclear, however autoimmune
origin has been consolidated by the recent discoveries
of Lunardi et al. as a result of the dysregulation of
the response of B and T lymphocytes, as is also demon-
strated in ANCA-associated glomerulonephritis, in chil-
dren with sensorineural hearing loss including Cogan
syndrome [15]. In addition, immunosuppressive agents
such as mycophenolate mofetil or cyclophosphamide
are partly effective for quieting disease activity in both
diseases, indicating involvement of cellular and humoral
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eases [1,16]. Since chlamydia pneumoniae infection as
the antecedent infection is demonstrated in some pa-
tients with two respective diseases [12,17], such patho-
gen might be involved in our patient, however precise
pathogenesis remains uncertain.
PSL is the first choice for treatment of this disease.
About 50% of patients respond favorably [1]. However,
repeated remissions and exacerbations occur in many
patients, leading to total hearing loss in 50% [1]. In PSL-
resistant patients, immunosuppressants such as metho-
trexate, cyclophosphamide, azathioprine, and rituximab
are used [1]. De Groot et al. [18] reported that the meth-
otrexiate regimen in their treatment was less effective
for induction of remission in patients with extensive
ANCA-associated vasculitis and was associated with
more relapses than the cyclophosphamide regimen after
termination of treatment by randomized trial of these
two drugs. Additionally, rituximab, mycophenolate mo-
fetil, or azathioprine is off-label prescribing for this dis-
ease on Japan national health insurance system. Thus,
we employed cyclophosphamide for our patient’s initial
treatment. However, despite of this treatment, sufficient
efficacy against his condition could not be obtained,
therefore we employed CyA as the second-line treat-
ment. On the other hand, a patient treated very early,
resulting in complete recovery has been reported [19].
In our patient, PSL combined with an immunosuppres-
sant was used relatively early, which may have avoided
rapid progression of renal dysfunction and aortitis. We
believe that ongoing immunosuppressant therapy will be
necessary in this patient. Since collagen vascular diseases
such as systemic lupus erythematosus [20] and Wegener
granulomatosis [21] have been reported as complications
of Cogan syndrome, follow-up with attention to their
possible development is necessary.
Conclusions
In summary, we encountered an adolescent with Cogan
syndrome, which rarely occurs in childhood. In addition to
aortitis, ANCA-associated glomerulonephritis, not previ-
ously reported as a complication, occurred in this patient.
Therefore, evaluation of aortitis in childhood requires not
only otolaryngologic and ophthalmologic examinations, but
also periodic urine examination and renal function tests for
early detection of renal complications.
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